{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-027440","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2023-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.657554+00:00","generated_at":"2026-06-11T17:50:02.242034+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Oncocyte Q2 revenue $0.5M, net operating loss $8.3M; appoints James Liu interim CFO","bullets":["Revenue $0.5M, cost of revenue $0.2M; net operating loss $8.3M vs $8.6M YoY, down $0.3M.","Cash, equivalents, and marketable securities $17.9M at June 30; avg cash burn below $5M/qtr in 2H 2023.","R&D expense down 56% YoY to $2.4M; G&A down 36% to $3.5M; S&M down 77% to $0.8M.","Transplant product launch on track for Q4 early access; MolDX coverage reviews ongoing.","James Liu (age 28) promoted to Sr. Director, Controller & PAO; appointed interim Principal Financial Officer; salary $200K, target bonus 35%."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-027440","json":"https://secwatch.observer/filing/0001493152-23-027440.json","markdown":"https://secwatch.observer/filing/0001493152-23-027440.md","text":"https://secwatch.observer/filing/0001493152-23-027440.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223027440/0001493152-23-027440-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223027440/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T17:50:02.242034+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"284a4cee5c67d7c0f33b390d626a35668cc4cf42","claim":"Insight Molecular Diagnostics Inc. reported Second Quarter 2023 results: revenue 0.5 million.","evidence_excerpt":"Consolidated revenues for the second quarter of 2023 were approximately $0.5 million, and cost of revenues for the second quarter were approximately $0.2 million, primarily from services customers.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223027440/0001493152-23-027440-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Second Quarter 2023"},{"label":"Revenue","value":"0.5 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"0cae1e84d7","claim":"James Liu was appointed as interim Principal Financial Officer at Insight Molecular Diagnostics Inc..","evidence_excerpt":"On that same date, the Company appointed Mr. Liu to the additional role of interim Principal Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223027440/0001493152-23-027440-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Principal Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"7615bf7543","claim":"James Liu changed role as Senior Director, Controller & Principal Accounting Officer at Insight Molecular Diagnostics Inc..","evidence_excerpt":"On August 4, 2023, the Company promoted James Liu to Senior Director, Controller & Principal Accounting Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223027440/0001493152-23-027440-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Senior Director, Controller & Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}